Tasimelteon
Active substance: tasimelteon
CAPSULE · TASIMELTEON 20 mg/1
United StatesActive
Marketing holder: Apotex Corp.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TASIMELTEON · 20 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-18be-7e47-a269-36bf3c53630d,01a1208e-fde3-7a6a-adf4-7714b09a3bac,01a12094-8f54-7322-9ac7-29bbbea67f78,01a12096-7a4d-7234-bc21-0bc6714342e4,01a1209d-5343-7183-8e00-eb0e351b4c5d;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 60505-4665
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 60505-4665 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 60505-4665 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 60505-4665 · Verified 2026-10-09 · open in source